Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever — Stella

Home/Safety Issues/

View on ClinicalTrials.gov

Recruiting

Back to Safety Issues trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Blood & Marrow Transplantation Center, RuiJin Hospital, Shanghai, Shanghai Municipality

Key details

Sponsor

Shanghai Jiao Tong University School of Medicine

Enrollment target

~200 participants

Started

January 2020

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.